Concourse Financial Group Securities, Inc. Cor Medix Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.56 Billion
Q2 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share
Q2 2024 Jul 23, 2024	BUY	$4.08 - $6.39 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$2.94 - $4.24 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$3.0 - $4.01 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$3.6 - $4.46 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$3.6 - $4.46 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$3.94 - $5.8 $0 - $0
Q1 2023 May 15, 2023	BUY	$3.22 - $4.61 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$2.81 - $4.45 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$2.82 - $7.52 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$2.73 - $5.61 $0 - $0
Q1 2022 May 09, 2022	BUY	$3.83 - $6.24 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$4.47 - $5.56 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$4.46 - $7.11 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$6.05 - $10.09 $0 - $0
Q1 2021 May 13, 2021	BUY	$6.84 - $17.58 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$5.0 - $9.15 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$3.96 - $6.15 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$3.08 - $6.56 $0 - $0
Q1 2020 May 13, 2020	BUY	$2.35 - $7.08 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$4.96 - $7.75 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$6.38 - $9.69 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$5.93 - $10.57 $0 - $0
Q1 2019 May 15, 2019	BUY	$6.95 - $13.25 $0 - $0

Others Institutions Holding CRMD

# of Institutions

101

Shares Held

16.9M

Call Options Held

70.5K

Put Options Held

358K

Black Rock Inc. New York, NY

3.55M
Shares

$25.8 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.9M
Shares

$21 Million
0.0% of portfolio
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl

1.55M
Shares

$11.2 Million
0.04% of portfolio
Nomura Holdings Inc Tokyo, M0

1.42M
Shares

$10.3 Million
0.01% of portfolio
Geode Capital Management, LLC Boston, MA

1.27M
Shares

$9.22 Million
0.0% of portfolio

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $299M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account